/PRNewswire/ Novotech Health Holdings Pte. Ltd. ("Novotech Holdings" or the "Company") today announced the completion of a financing round of US$760 million.
/PRNewswire/ Novotech Health Holdings Pte. Ltd. ("Novotech Holdings" or the "Company") today announced the completion of a financing round of US$760 million.
Novotech Completes $255M Private Placement Transaction and $505M Refinancing to Accelerate Implementation of Growth Initiatives streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Novotech Health Holdings Appoints Andy Liu as Head of China
January 29, 2021 GMT
SHANGHAI and SYDNEY, Jan. 28, 2021 /PRNewswire/ Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia, today announced the appointment of Andy Liu as Head of China. Andy will be responsible for developing Novotech Holding’s business in China to better serve local and multinational biotech companies operating in the region. Operating under the PPC brand, Novotech’s China business incorporates a full service CRO, clinical trial site management organisation (SMO) services, Phase 1 units and bioanalytical laboratories. China is one of the fastest growing markets for clinical research services globally.